Solid hyaluronic acid film and the prevention of postoperative fibrous scar formation in experimental animal eyes

Archives of Ophthalmology

Volumn 127, Issue 4, 2009, Pages 460-464

  Takeuchi, Kimio ^a   Nakazawa, Mitsuru ^a,b   Yamazaki, Hitoshi ^a   Miyagawa, Yasuhiro ^a   Ito, Tadashi ^a   Ishikawa, Futoshi ^a   Metoki, Tomomi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBOXYMETHYLCELLULOSE; CELL NUCLEUS ANTIGEN; HYALURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL ANIMAL; EYE INJURY; EYE SURGERY; FILM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RABBIT; SCAR FORMATION; SCLERA; TRABECULECTOMY;

ACTINS; ANIMALS; CARBOXYMETHYLCELLULOSE; CELL COUNT; CICATRIX; CONJUNCTIVA; FIBROSIS; HYALURONIC ACID; IMMUNOENZYME TECHNIQUES; MEMBRANES, ARTIFICIAL; POSTOPERATIVE COMPLICATIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; RABBITS; SCLERA; SURGICAL FLAPS; TRABECULECTOMY;

EID: 65249158537     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.70     Document Type: Article

References (25)

1. Bowers D, Raybon RB, Wheeless CR Jr. Hyaluronic acid-carboxymethylcellu- lose film and perianastomotic adhesions in previously irradiated rats. Am J Obsten Gynecol. 1999;181(6):1335-1337, discussion 1137-1138.
2. Hellebrekers BW, Trimbos-Kemper GC, van Blitterswijk CA, Bakkum EA, Trim-bos JB. Effects of five different barrier materials on postsurgical adhesion formation in the rat. Hum Reprod. 2000;15(6):1358-1363.
3. Osada H, Minai M, Tsunoda I, Fujii TK, Tsubata K, Satoh K. The effect of hyaluronic acid-carboxymethylcellulose in reducing adhesion reformation in rabbits. JIntMed Res. 1999;27(6):292-296.
4. van't Riet M, de Vos van Steenwijk PJ, Bonthuis F, etal. Prevention of adhesion to prosthetic mesh. Ann Surg. 2003;237(1):123-128.
5. Burns JW, Colt MJ, Burgees LS, Skinner KC. Preclinical evaluation of Seprafilm bioresorbable membrane. Eur J Surg Suppl. 1997;(577):40-48.
6. Three-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 1993;115(1):82-92.
7. Kitazawa Y, Kawase K, Matsushita H, Minobe M. Trabeculectomy with mitomycin. Arch Ophthalmol. 1991;109(12):1693-1698.
8. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 1991;98(3):317-321.
9. Kitazawa Y, Suemori-Matsushita H, Yamamoto T, Kawase K. Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. Ophthalmology. 1993;100(11):1624-1628.
10. Belyea DA, Dan JA, Lieberman MF, Stamper RL. Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure. J Glaucoma. 1997;6(2):90-98.
11. Greenfield DS, Parrish RK II. Bleb rupture following filtering surgery with mitomycin C. Ophthalmic Surg Lasers. 1996;27(10):876-877.
12. Sihota R, Dada T, Gupta SD, Sharma S, Arora R, Agarwal HC. Conjunctival dysfunction and mitomycin C-induced hypotony. JGlaucoma. 2000;9(5):392-397.
13. Belyea DA, Dan JA, Stamper RL, Lieberman MF, Spencer WH. Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluoroura- cil and mitomycin C. Am J Ophthalmol. 1997;124(1):40-45.
14. Mochizuki K, Jikihara S, Ando Y, Hori N, Yamamoto T, Kitazawa Y. Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluo-rouracil treatment. Br J Ophthalmol. 1997;81(10):877-883.
15. Solomon A, Ticho U, Frucht-Pery J. Late onset, bleb associated endophthalmitis following glaucoma filtering surgery with or without antifibrotic agents. J Ocul Pharmacol Ther. 1999;15(4):283-293.
16. Poulsen EJ, Allingham RR. Characteristics and risk factors of infections after glaucoma filtering surgery. JGlaucoma. 2000;9(6):438-443.
17. Molteno AC, Straughan JL, Ancker E. Long tube implants in the managementof glaucoma. SAfrMedJ. 1976;50(27):1062-1066.
18. Lee D, Shin DH, Birt CM, et al. The effect of adjunctive mitomycin C in Molteno implant surgery. Ophthalmology. 1997;104(12):2126-2135.
19. Lloyd MA, Baerveldt G, Heuer DK, Minckler DS, Martone JF. Initial clinical experience with the Baerveldt implant in complicated glaucomas. Ophthalmology. 1994; 101(4):640-650.
20. Tsai JC, Johnson CC, Dietrich MS. The Ahmed shuntversus the Baerveldt shunt for refractory glaucoma. Ophthalmology. 2003;110(9):1814-1821.
21. Grehn F, Holló G, Khaw P, et al; CAT-152 Trabeculectomy Study Group. Factors affecting the outcome of trabeculectomy. Ophthalmology. 2007;114(10):1831- 1838.
22. Khaw P, Grehn F, Holló G, etal; CAT-1520102 Trabeculectomy Study Group. A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology. 2007;114(10):1822-1830.
23. Burns JW, Colt MJ, Burgees LS, Skinner KC. Preclinical evaluation of Seprafilm bioresorbable membrane. Eur J Surg Suppl. 1997;(577):40-48.
24. Erkek AB, Remzi FH, Hammel JP, AkyuzM, Fazio VW. Effect of small bowel obstruction on functional outcome and quality of life in patients with ileal pouch-anal anastomosis. J Gastroenterol Hepatol. 2008;23(1):119-125.
25. Micera A, Puxeddu I, Lambiase A, etal. The pro-fibrogeniceffect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-beta. Clin Exp Allergy. 2005;35(5):650-656.